vs
KELLY SERVICES INC（KELYA）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
KELLY SERVICES INC的季度营收约是Royalty Pharma plc的1.9倍（$1.2B vs $622.0M），Royalty Pharma plc同比增速更快（4.8% vs -3.3%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -3.1%）
凯利服务是1946年成立的美国跨国人力资源服务企业，总部位于密歇根州特洛伊市。公司可为金融服务、信息技术、法律等多个领域输送各层级雇员，核心业务涵盖人力资源管理咨询、业务外包、人才招聘、职业转型及供应商管理等专业服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
KELYA vs RPRX — 直观对比
营收规模更大
KELYA
是对方的1.9倍
$622.0M
营收增速更快
RPRX
高出8.1%
-3.3%
两年增速更快
RPRX
近两年复合增速
-3.1%
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | — | $214.2M |
| 毛利率 | 20.3% | — |
| 营业利润率 | -4.8% | 62.4% |
| 净利率 | — | 34.4% |
| 营收同比 | -3.3% | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | $-0.86 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KELYARPRX
| Q4 25 | — | $622.0M | ||
| Q3 25 | — | $609.3M | ||
| Q2 25 | — | $578.7M | ||
| Q1 25 | — | $568.2M | ||
| Q4 24 | $1.2B | $593.6M | ||
| Q3 24 | $1.0B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $1.0B | $568.0M |
净利润KELYARPRX
| Q4 25 | — | $214.2M | ||
| Q3 25 | — | $288.2M | ||
| Q2 25 | — | $30.2M | ||
| Q1 25 | — | $238.3M | ||
| Q4 24 | — | $208.2M | ||
| Q3 24 | $800.0K | $544.0M | ||
| Q2 24 | $4.6M | $102.0M | ||
| Q1 24 | $25.8M | $4.8M |
毛利率KELYARPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.3% | — | ||
| Q3 24 | 21.4% | — | ||
| Q2 24 | 20.2% | — | ||
| Q1 24 | 19.7% | — |
营业利润率KELYARPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | — | 70.1% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | -4.8% | 60.9% | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 1.2% | 50.2% | ||
| Q1 24 | 2.6% | -13.0% |
净利率KELYARPRX
| Q4 25 | — | 34.4% | ||
| Q3 25 | — | 47.3% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 35.1% | ||
| Q3 24 | 0.1% | 96.3% | ||
| Q2 24 | 0.4% | 19.0% | ||
| Q1 24 | 2.5% | 0.8% |
每股收益（稀释后）KELYARPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | $-0.86 | $0.46 | ||
| Q3 24 | $0.02 | $1.21 | ||
| Q2 24 | $0.12 | $0.23 | ||
| Q1 24 | $0.70 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.0M | $618.7M |
| 总债务越低越好 | $239.4M | $9.0B |
| 股东权益账面价值 | $1.2B | $9.7B |
| 总资产 | $2.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资KELYARPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $39.0M | $929.0M | ||
| Q3 24 | $32.8M | $950.1M | ||
| Q2 24 | $38.2M | $1.8B | ||
| Q1 24 | $200.7M | $843.0M |
总债务KELYARPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $239.4M | $7.6B | ||
| Q3 24 | $228.2M | $7.6B | ||
| Q2 24 | $210.4M | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益KELYARPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | — | $9.6B | ||
| Q2 25 | — | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | $1.2B | $10.3B | ||
| Q3 24 | $1.3B | $10.3B | ||
| Q2 24 | $1.3B | $9.8B | ||
| Q1 24 | $1.3B | $9.9B |
总资产KELYARPRX
| Q4 25 | — | $19.6B | ||
| Q3 25 | — | $19.3B | ||
| Q2 25 | — | $18.3B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | $2.6B | $18.2B | ||
| Q3 24 | $2.7B | $18.0B | ||
| Q2 24 | $2.6B | $17.7B | ||
| Q1 24 | $2.4B | $16.1B |
负债/权益比KELYARPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.19× | 0.74× | ||
| Q3 24 | 0.18× | 0.74× | ||
| Q2 24 | 0.16× | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $13.0M | — |
| 自由现金流率自由现金流/营收 | 1.1% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $15.8M | — |
8季度趋势，按日历期对齐
经营现金流KELYARPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | — | $702.6M | ||
| Q2 25 | — | $364.0M | ||
| Q1 25 | — | $596.1M | ||
| Q4 24 | $15.0M | $742.5M | ||
| Q3 24 | $-20.3M | $703.6M | ||
| Q2 24 | $57.7M | $658.2M | ||
| Q1 24 | $-25.5M | $664.6M |
自由现金流KELYARPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $13.0M | — | ||
| Q3 24 | $-22.7M | — | ||
| Q2 24 | $54.7M | — | ||
| Q1 24 | $-29.2M | — |
自由现金流率KELYARPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | -2.2% | — | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | -2.8% | — |
资本支出强度KELYARPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.4% | — |
现金转化率KELYARPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | -25.38× | 1.29× | ||
| Q2 24 | 12.54× | 6.45× | ||
| Q1 24 | -0.99× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KELYA
| Science Engineering Technology | $295.8M | 25% |
| Education | $293.1M | 25% |
| Staffing Services | $237.7M | 20% |
| Other | $138.8M | 12% |
| Talent Solutions | $120.5M | 10% |
| Outcome Based Services | $103.6M | 9% |
| Permanent Placement | $1.6M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
